BAKER BROS ADVISORS LLC Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in IDERA PHARMACEUTICALS, INC.
Trading Symbol: IDRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner, Director
Holdings: 350,721 shares
Current Value: $547,125
Latest Transaction: Jul 03 2019
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in IDERA PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Grant | A | 2.61 | 2,964 | 7,736 | 4,290,995 | 4.3 M to 4.3 M (+0.07 %) |
Jul 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Grant | A | 2.61 | 2,964 | 7,736 | 350,721 | 347.8 K to 350.7 K (+0.85 %) |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 880 | 70 | 880 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 1,660 | 133 | 1,660 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,256 | 500 | 6,256 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 880 | 70 | 880 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 1,660 | 133 | 1,660 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,256 | 500 | 6,256 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,009 | 481 | 0 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 11,337 | 907 | 0 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 42,724 | 3,418 | 0 | |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | J | 0.00 | 21,929 | 0 | 21,929 | 0 to 21.9 K |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | J | 0.00 | 21,929 | 0 | 21,929 | 0 to 21.9 K |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | J | 0.00 | 59,267 | 0 | 0 | 59.3 K to 0 (-100.00 %) |
Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | J | 0.00 | 178,967 | 0 | 347,757 | 526.7 K to 347.8 K (-33.98 %) |
Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 89,233 | 85.1 K to 89.2 K (+4.89 %) |
Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 4,288,031 | 4.3 M to 4.3 M (+0.10 %) |
Apr 03 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.59 | 4,161 | 10,777 | 526,724 | 522.6 K to 526.7 K (+0.80 %) |
Jan 04 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 3.52 | 3,658 | 12,876 | 85,072 | 81.4 K to 85.1 K (+4.49 %) |
Jan 04 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 3.52 | 3,658 | 12,876 | 4,283,870 | 4.3 M to 4.3 M (+0.09 %) |
Jan 04 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 3.52 | 3,658 | 12,876 | 522,563 | 518.9 K to 522.6 K (+0.70 %) |
Oct 03 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 8.71 | 2,340 | 20,381 | 81,414 | 79.1 K to 81.4 K (+2.96 %) |
Oct 03 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 8.71 | 2,340 | 20,381 | 4,280,212 | 4.3 M to 4.3 M (+0.05 %) |
Oct 03 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 8.71 | 2,340 | 20,381 | 518,905 | 516.6 K to 518.9 K (+0.45 %) |
Jul 05 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.32 | 16,383 | 21,626 | 632,599 | 616.2 K to 632.6 K (+2.66 %) |
Jul 05 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.32 | 16,383 | 21,626 | 34,222,983 | 34.2 M to 34.2 M (+0.05 %) |
Jul 05 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.32 | 16,383 | 21,626 | 4,132,528 | 4.1 M to 4.1 M (+0.40 %) |
Jun 21 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 1.53 | 100,000 | 153,000 | 100,000 | |
Apr 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.62 | 13,349 | 21,625 | 616,216 | 602.9 K to 616.2 K (+2.21 %) |
Apr 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.62 | 13,349 | 21,625 | 34,206,600 | 34.2 M to 34.2 M (+0.04 %) |
Apr 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.62 | 13,349 | 21,625 | 4,116,145 | 4.1 M to 4.1 M (+0.33 %) |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 439,036 | 206,347 | 0 | |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 17,626,445 | 8,284,429 | 0 | |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 2,250,846 | 1,057,898 | 0 | |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 439,036 | 206,347 | 602,867 | 163.8 K to 602.9 K (+267.98 %) |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 17,626,445 | 8,284,429 | 34,193,251 | 16.6 M to 34.2 M (+106.40 %) |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 2,250,846 | 1,057,898 | 4,102,796 | 1.9 M to 4.1 M (+121.54 %) |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 163,831 | 154.5 K to 163.8 K (+6.04 %) |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 16,566,806 | 16.6 M to 16.6 M (+0.06 %) |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 1,851,950 | 1.8 M to 1.9 M (+0.51 %) |
Oct 30 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 1.50 | 7,204,652 | 10,806,978 | 16,557,473 | 9.4 M to 16.6 M (+77.03 %) |
Oct 30 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 1.50 | 795,348 | 1,193,022 | 1,842,617 | 1 M to 1.8 M (+75.94 %) |
Oct 04 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.28 | 9,045 | 20,623 | 154,498 | 145.5 K to 154.5 K (+6.22 %) |
Oct 04 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.28 | 9,045 | 20,623 | 9,352,821 | 9.3 M to 9.4 M (+0.10 %) |
Oct 04 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.28 | 9,045 | 20,623 | 1,047,269 | 1 M to 1 M (+0.87 %) |
Jul 06 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.75 | 11,787 | 20,627 | 145,453 | 133.7 K to 145.5 K (+8.82 %) |
Jul 06 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.75 | 11,787 | 20,627 | 9,343,776 | 9.3 M to 9.3 M (+0.13 %) |
Jul 06 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.75 | 11,787 | 20,627 | 1,038,224 | 1 M to 1 M (+1.15 %) |
Jun 08 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 1.63 | 100,000 | 163,000 | 100,000 | |
Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 133,666 | 125.2 K to 133.7 K (+6.78 %) |
Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 9,331,989 | 9.3 M to 9.3 M (+0.09 %) |
Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 1,026,437 | 1 M to 1 M (+0.83 %) |
Page: 1